Grey Fox Wealth Advisors’s ResMed RMD Stock Holding History

Grey Fox Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10	Closed	-$2.74K	–	498
2025 Q3	$2.74K	Buy	+10	New	+$2.73K	﹤0.01%	523

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Grey Fox Wealth Advisors's RMD Position: Q4 2025 in Review

Grey Fox Wealth Advisors sold out of ResMed (RMD) in Q4 2025, closing a stake of 10 shares — an estimated $2.74K sold.

Grey Fox Wealth Advisors first reported a position in RMD in Q3 2025 and held it in 1 quarter. The position peaked at $2.74K in Q3 2025. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Grey Fox Wealth Advisors reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Grey Fox Wealth Advisors sold 10 ResMed shares in Q4 2025, an estimated $2.74K.
Grey Fox Wealth Advisors first reported a position in ResMed in Q3 2025 and held it in 1 quarter.
Grey Fox Wealth Advisors's ResMed position peaked at $2.74K in Q3 2025.
946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Grey Fox Wealth Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.